“An Unrelenting Disaster Zone”: Merck’s Alzheimer’s Drug Fails in Phase III Post author:Sam Post published:February 13, 2018 Post category:BioPharma Alzheimer’s drug development took another hit. Source: BioSpace You Might Also Like This Drug Could Rattle Biogen and Be the Next Billion-Dollar Blockbuster for Celgene February 19, 2017 Two Biotech Startups With a Shot at Reaching a Billion-Dollar Valuation September 26, 2017 North Korean Biotech Institute Allegedly Involved in the Killing of Leader Half Brother February 21, 2017
This Drug Could Rattle Biogen and Be the Next Billion-Dollar Blockbuster for Celgene February 19, 2017
North Korean Biotech Institute Allegedly Involved in the Killing of Leader Half Brother February 21, 2017
